Skip to main content
SpringerLink
Log in

Peritonitis

  • Chapter
Book cover Textbook of Peritoneal Dialysis

Abstract

Peritonitis remains a major complication of peritoneal dialysis, accounting for much of the morbidity associated with the technique. Peritonitis accounts for 15–35% of hospital admissions and is the major cause of transfer to haemodialysis (technique failure) [1–6]. High peritonitis rates are associated with mortality, either as a primary or contributing factor [2, 7–10].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. J Am Soc Nephrol 1996; 7: 198–207.

    Google Scholar 

  2. Pollock CA, Ibels LS, Caterson RJ, Mahony JF, Waugh DA, Cocksedge B: Continuous ambulatory peritoneal dialysis: eight years of experience at a single center. Medicine 1989; 68: 293–308.

    Article  PubMed  CAS  Google Scholar 

  3. Saade M, Joglar F. Chronic peritoneal dialysis: seven-year experience in a large Hispanic program. Petit Dial Int 1995; 15: 37–41.

    CAS  Google Scholar 

  4. Viglino G, Cancarini G, Catizone L et al. The impact of peritonitis on CAPD results. Adv Petit Dial 1992; 8: 269–75.

    CAS  Google Scholar 

  5. Woodrow G, Turney JH, Brownjohn AM. Technique failure in peritoneal dialysis and its impact on patient survival. Petit Dial Int 1997; 17: 360–4.

    CAS  Google Scholar 

  6. Fried L, Syed Abidi S, Bernardini J, Johnston JR, Piraino B. Hospitalization in peritoneal dialysis patients. Am J Kidney Dis (In press).

    Google Scholar 

  7. Bloembergen WE, Port FK. Epidemiological perspective on infections in chronic dialysis patients. Adv Renal Replacement Ther 1996; 3: 201–7.

    CAS  Google Scholar 

  8. Fried LF, Bernardini J, Johnston JR, Piraino B. Peritonitis influences mortality in peritoneal dialysis patients. J Am Soc Nephrol 1996; 7: 2176–82.

    PubMed  CAS  Google Scholar 

  9. Rubin J, Hsu H. Continuous ambulatory peritoneal dialysis: ten years at one facility Am J Kidney Dis 1991; 17: 165–9.

    CAS  Google Scholar 

  10. Slingeneyer A, Mion C, Beraud JJ, Branger B, Balmes M. Peritonitis, a frequently lethal complication of intermittent and continuous peritoneal dialysis. Proc Eur Dial Transplant Assoc 1981; 18: 212–21.

    PubMed  CAS  Google Scholar 

  11. Rubin J, Rogers WA, Taylor HM et al. Peritonitis during continuous ambulatory peritoneal dialysis. Ann Intern Med 1980; 92: 7–13.

    Article  PubMed  CAS  Google Scholar 

  12. De Vecchi AF, Maccario M, Braga M, Scalamogna A, Castelnovo C, Ponticelli C. Peritoneal dialysis in nondiabetic patients older than 70 years: comparison with patients age 40 to 60 years. Am J Kidney Dis 1998; 31: 479–90.

    Article  PubMed  Google Scholar 

  13. Tzamaloukas AH, Murata GH, Fox L. Peritoneal catheter loss and death in continuous ambulatory peritoneal dialysisperitonitis: correlation with clinical and biochemical parameters. Petit Dial Int 1992; 13 (suppl. 2): 5338–40.

    Google Scholar 

  14. Bunke CM, Brier ME, Golper TA, for the Academic Subcommittee of the Network 9 Peritonitis Study. Outcomes of single organism peritonitis in peritoneal dialysis: gram-negatives versus gram positives in the Network 9 Peritonitis Study. Kidney Int 1997; 52: 524–9.

    Article  PubMed  Google Scholar 

  15. Troidle L, Gorban-Brennan N, Kliger A, Finkelstein F. Differing outcomes of gram-positive and gram-negative peritonitis. Am J Kidney Dis 1998; 32: 623–8.

    Article  PubMed  CAS  Google Scholar 

  16. Fenton S, Wu G, Cattran D, Wadgymar A, Allen AF. Clinical aspects of peritonitis in patients on CAPD. Petit Dial Bull 1981; 1 (suppl. 6): S4–7.

    Google Scholar 

  17. Grefberg N, Danielson BG, Nilsson P. Peritonitis in patients on continuous ambulatory peritoneal dialysis: a changing scene. Scand J Infect Dis 1984; 16: 187–93.

    Article  PubMed  CAS  Google Scholar 

  18. Domrongkitchaiporn S, Karim M, Watson L, Moriarty M. The influence of continuous ambulatory peritoneal dialysis connection technique on peritonitis rate and technique survival. Am J Kidney Dis 1994; 24: 50–8.

    PubMed  CAS  Google Scholar 

  19. Holley JL, Bernardini J, Piraino B. Infecting organisms in continuous ambulatory peritoneal dialysis patients on the Y-set. Am J Kidney Dis 1994; 23: 569–73.

    PubMed  CAS  Google Scholar 

  20. Tranaeus A, Heimburger O, Lindholm B. Peritonitis in continuous ambulatory peritoneal dialysis (CAPD): diagnostic findings, therapeutic outcome and complications. Petit Dial Int 1989; 9: 179–90.

    CAS  Google Scholar 

  21. Van Biesen W, Vanholder R, Vogelaers D et al. The need for a center-tailored treatment protocol for peritonitis. Petit Dial Int 1998; 18: 274–81.

    Google Scholar 

  22. Peterson PK, Matzke G, Keane WF. Current concepts in the management of peritonitis in patients undergoing continuous ambulatory peritoneal dialysis. Rev Infect Dis 1987; 9: 604–12.

    Article  PubMed  CAS  Google Scholar 

  23. Golper TA, Brier ME, Bunke M et al. for the Academic Subcommittee of the Steering Committee of the Network 9 Peritonitis and Catheter Survival Studies. Risk factors for peritonitis in long-term peritoneal dialysis: Network 9 Peritonitis and Catheter Survival Studies. Am J Kidney Int 1996; 28: 428–36.

    Article  CAS  Google Scholar 

  24. Canadian CAPD Clinical Trials Group. Peritonitis in continuous ambulatory peritoneal dialysis (CAPD): a multicenter randomized clinical trial comparing the Y connector disinfectant system to standard systems. Petit Dial Int 1989; 9: 159–63.

    Google Scholar 

  25. Goldie SJ, Kiernan-Troidle L, Torres C et al. Fungal peritonitis in a large chronic peritoneal dialysis population: a report of 55 episodes. Am J Kidney Dis 1996; 28: 86–91.

    Article  PubMed  CAS  Google Scholar 

  26. Johnson RJ, Ramsey PG, Gallagher N, Ahmad S. Fungal peritonitis in patients on peritoneal dialysis: incidence, clinical features and prognosis. Am J Nephrol 1985; 5: 169–75.

    Article  PubMed  CAS  Google Scholar 

  27. Eisenberg ES, Leviton I, Soeiro R. Fungal peritonitis in patients receiving peritoneal dialysis: experience with 11 patients and review of the literature. Rev Infect Dis 1986; 8: 309–20.

    Article  PubMed  CAS  Google Scholar 

  28. Michel C, Courdavault L, Al Khayat R, Viron B, Roux P, Mignon F. Fungal peritonitis in patients on peritoneal dialysis. Am J Nephrol 1994; 14: 113–20.

    Article  PubMed  CAS  Google Scholar 

  29. Winton MD, Everett ED. Antimicrobial therapy for CAPDassociated peritonitis. Blood Purif 1989; 7: 115–25.

    Article  PubMed  CAS  Google Scholar 

  30. Vas SI. The diagnosis and treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis. Semin Dial 1995; 8: 232–7.

    Article  Google Scholar 

  31. Rotellar C, Sivarajan S, Mazzoni MJ et al. Bowel perforation in CAPD patients. Petit Dial Int 1992; 12: 396–8.

    CAS  Google Scholar 

  32. Van Reijden HJ, Struijik DG, van Ketel RJ, Kox C, Krediet RT, Arisz L. Fecal peritonitis in patients on continuous ambulatory peritoneal dialysis, an end-point in CAPD? Adv Petit Dial 1988; 4: 198–203.

    Google Scholar 

  33. Bustos E, Rotellar C, Mazzoni MJ, Rakowski TA, Argy WP, Winchester JF. Clinical aspects of bowel perforation in

    Google Scholar 

  34. Holley JL, Bernardini J, Piraino B. Polymicrobial peritonitis in patients on continuous peritoneal dialysis. Am J Kidney Dis 1992; 19: 162–6.

    PubMed  CAS  Google Scholar 

  35. Lui SL, Lo CY, Choy BY, Chan TM, Lo WK, Cheng IPK. Optimal treatment and long-term outcome of tuberculous peritonitis complicating continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1996; 28: 747–51.

    Article  PubMed  CAS  Google Scholar 

  36. Vas S. Microbiological aspects of peritonitis. Petit Dial Bull 1981; 1: S11–14.

    Google Scholar 

  37. Bazzato G, Coli U, Landini S et al. The double bag system for CAPD reduces the peritonitis rate. Trans Am Soc Artif Intern Organs 1984; 30: 690–2.

    PubMed  CAS  Google Scholar 

  38. Bonnardeaux A, Ouimet D, Galarneau A et al. Peritonitis in continuous ambulatory peritoneal dialysis: impact of a compulsory switch from a standard to a Y-connector system in single North American center. Am J Kidney Dis 1992; 29: 364–70.

    Google Scholar 

  39. Dryden MS, McCann M, Wing AJ, Phillips I. Controlled trial of a Y-set dialysis delivery system to prevent peritonitis in patients receiving continuous ambulatory peritoneal dialysis. J Hosp Infect 1992; 20: 185–92.

    Article  PubMed  CAS  Google Scholar 

  40. Grutzmacher P, Tsobanelis T, Bruns M, Kurz P, Hoppe D, Vlachojannis J. Decrease in peritonitis rate by integrated disconnect system in patients on continuous ambulatory peritoneal dialysis. Petit Dial Int 1992; 13 (suppl. 2): S326–8.

    Google Scholar 

  41. Vas SI. Etiology and treatment of peritonitis. Trans Am Soc Artif Intern Organs 1984; 30: 682–4.

    PubMed  CAS  Google Scholar 

  42. Gupta B, Bernardini J, Piraino B. Peritonitis associated with exit site and tunnel infections. Am J Kidney Dis 1996; 28: 415–19.

    Article  PubMed  CAS  Google Scholar 

  43. Read RR, Eberwein P, Dasgupta MK et al. Peritonitis in peritoneal dialysis: bacterial colonization by biofilm spread along the catheter surface. Kidney Int 1989; 35: 614–21.

    Article  PubMed  CAS  Google Scholar 

  44. Piraino B, Bernardini J, Sorkin M. The influence of peritoneal catheter exit-site infections on peritonitis, tunnel infections, and catheter loss in patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1986; 8: 436–40.

    PubMed  CAS  Google Scholar 

  45. Scalamogna A, Castelnovo C, De Vecchi A, Ponticelli C. Exit-site and tunnel infections in continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1991; 18: 674–7.

    PubMed  CAS  Google Scholar 

  46. Dasgupta MK, Costerton JW. Significance of biofilm-adherent bacterial microcolonies on Tenckhoff catheters of CAPD patients. Blood Purif 1989; 7: 144–55.

    Article  PubMed  CAS  Google Scholar 

  47. Tzamaloukas AH, Hartshorne MF, Gibel LJ, Murata GH. Persistence of positive dialysate cultures after apparent cure of CAPD peritonitis. Adv Petit Dial 1993; 9: 198–201.

    CAS  Google Scholar 

  48. Swartz R, Messana J, Holmes C, Williams J. Biofilm formation on peritoneal catheters does not require the presence of infection. Trans Am Soc Artif Intern Organs 1991; 37: 626–33.

    CAS  Google Scholar 

  49. Verger C, Danne O, Vuillemin F. Colonoscopy and continuous ambulatory peritoneal dialysis. Gastroint Endosc 1987; 33: 334–5.

    Article  CAS  Google Scholar 

  50. Sprenger R, Neyer U. Enterococcus peritonitis after endoscopic polypectomy: need for prophylactic antibiotics. Petit Dial Bull 1987; 7: 263–4.

    Google Scholar 

  51. Holley J, Seibert M, Moss A. Peritonitis following colonoscopy: a need for prophylaxis? Petit Dial Bull 1987; 7: 105–6.

    Google Scholar 

  52. Maruyama H, Nakamura T, Oya M et al. Posthysteroscopy Candida glabrata peritonitis in a patient on CAPD. Petit Dial Int 1997; 17: 404–5.

    CAS  Google Scholar 

  53. Troidle L, Kliger AS, Goldie SJ et al. Continuous peritoneal dialysis-associated peritonitis of nosocomial origin. Petit Dial Int 1996; 16: 505–10.

    CAS  Google Scholar 

  54. Ray SM, Piraino B, Holley J. Peritonitis following colonoscopy in a peritoneal dialysis patient. Petit Dial Int 1990; 10: 97–8.

    CAS  Google Scholar 

  55. Tzamaloukas AH, Obermiller LE, Gibel LJ et al. Peritonitis associated with intra-abdominal pathology in continuous ambulatory peritoneal dialysis. Petit Dial Int 1993; 13: S335–7.

    Google Scholar 

  56. Harwell CM, Newman LN, Cacho CP, Mulligan DC, Schulak JA, Friedlander MA. Abdominal catastrophe: visceral injury as a cause of peritonitis in patients treated by peritoneal dialysis. Petit Dial Int 1997; 17: 586–94.

    CAS  Google Scholar 

  57. Schweinburg FB, Seligman AM, Fine J. Transmural migration of intestinal bacteria: a study based on the use of radioactive Escherichia coli. New Engl J Med 1976; 242: 747–51.

    Article  Google Scholar 

  58. Caravaca F, Ruiz-Carlo R, Dominguez C. Risk factors for developing peritonitis caused by micro-organisms of enteral origin in peritoneal dialysis patients. Petit Dial Int 1998; 18: 41–5.

    CAS  Google Scholar 

  59. Singharetnam W, Holley JL. Acute treatment of constipation may lead to transmural migration of bacteria resulting in gram-negative, polymicrobial or fungal peritonitis. Petit Dial Int 1996; 16: 423–5.

    CAS  Google Scholar 

  60. Kiddy K, Brow PP, Michael J, Adu D. Peritonitis due to Streptococcus viridans in patients receiving continuous ambulatory peritoneal dialysis. Br Med J 1985; 290: 969.

    Article  CAS  Google Scholar 

  61. Levy M, Balfe JW. Optimal approach to the prevention and treatment of peritonitis in children undergoing continuous ambulatory and continuous cycling peritoneal dialysis. Sem Dial 1994; 7: 442–9.

    Article  Google Scholar 

  62. Bottoman VA, Surawicz CM. Bacteremia with gastrointestinal endoscopie procedures. Gastroint Endosc 1986; 32: 342–6.

    Article  Google Scholar 

  63. Durack DT. Prevention of infective endocarditis. N Engl J Med 1995; 332: 38–44.

    Article  PubMed  CAS  Google Scholar 

  64. Coward RA, Gokal R, Wise M, Mallick NP, Warrell D. Peritonitis associated with vaginal leakage of dialysis fluid in continuous ambulatory peritoneal dialysis. Br Med J 1982; 284: 1529.

    Article  CAS  Google Scholar 

  65. Swartz RD. Recurrent polymicrobial peritonitis from a gynecologic source as a complication of CAPD. Petit Dial Bull 1983; 3: 32–3.

    Google Scholar 

  66. Stuck A, Seiler A, Fry FJ. Peritonitis due to an intrauterine device in a patient on CAPD. Petit Dial Bull 1986; 6: 158–9.

    Google Scholar 

  67. Oxton LL, Zimmerman SW, Roeker EB, Wakeen M. Risk factors for peritoneal dialysis-related infections. Petit Dial Int 1994; 14: 137–44.

    CAS  Google Scholar 

  68. Korbet SM, Vonesh EF, Firanek CA. A retrospective assessment of risk factors for peritonitis among an urban CAPD population. Petit Dial Int 1993; 13: 126–31.

    CAS  Google Scholar 

  69. Fine A, Cox D, Bouw M. Higher incidence of peritonitis in Native Canadians on continuous ambulatory peritoneal dialysis. Petit Dial Int 1994; 14: 227–30.

    CAS  Google Scholar 

  70. Farias MG, Soucie JM, McClellan W, Mitch WE. Race and the risk of peritonitis: an analysis of factors associated with the initial episode. Kidney Int 1994; 46: 1392–6.

    Article  PubMed  CAS  Google Scholar 

  71. Juergensen PH, Juergensen DM, Wuerth DB et al. Psychosocial factors and the incidence of peritonitis. Adv Petit Dial 1996; 12: 196–8.

    CAS  Google Scholar 

  72. Nolph KD, Cuttler SJ, Steinberg SM, Novak JW. Continuous ambulatory peritoneal dialysis in the United States: a three-year study. Kidney Int 1985; 28: 198–205.

    Article  PubMed  CAS  Google Scholar 

  73. Holley JL, Bernardini J, Perlmutter JA, Piraino B. A comparison of infection rates among older and younger patients on continuous peritoneal dialysis. Petit Dial Int 1994; 14: 66–9.

    CAS  Google Scholar 

  74. Andrews PA, Warr KJ, Hicks JA, Cameron JS. Impaired outcome of continuous ambulatory peritoneal dialysis in immunosuppressed patients. Nephrol Dial Transplant 1996; 11: 1104–8.

    Article  PubMed  CAS  Google Scholar 

  75. Tebben JA, Rigsby MO, Selwyn PA, Brennan N, Kliger A, Finkelstein FO. Outcome of HIV infected patients on continuous ambulatory peritoneal dialysis. Kidney Int 1993; 44: 191–8.

    Article  PubMed  CAS  Google Scholar 

  76. Lewis M, Gorban-Brennan NL, Kliger A, Cooper K, Finkelstein FO. Incidence and spectrum of organisms causing peritonitis in HIV positive patients on CAPD. Adv Pent Dial 1990; 6: 136–8.

    CAS  Google Scholar 

  77. Bordes A, Campos-Herrero MI, Fernandez A, Vega N, Rodriguez JC, Palop L. Predisposing and prognostic factors of fungal peritonitis in peritoneal dialysis. Petit Dial Int 1995; 15: 275–6.

    CAS  Google Scholar 

  78. Kiernan L, Kliger A, Gorban-Brennan N et al. Comparison of continuous ambulatory peritoneal dialysis-related infections with different `Y-tubing’ exchange systems. J Am Soc Nephrol 1995; 5: 1835–8.

    PubMed  CAS  Google Scholar 

  79. Harris DCH, Yuill EJ, Byth K, Chapman JR, Hunt C. Twin-versus single-bag disconnect systems: infection rates and cost of continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 1996; 7: 2392–8.

    PubMed  CAS  Google Scholar 

  80. De Fijter CWH, Oe LP, Nauta JJP et al. Clinical efficacy and morbidity associated with continuous cyclic compared with continuous ambulatory peritoneal dialysis. Ann Intern Med 1994; 120: 264–71.

    Article  PubMed  Google Scholar 

  81. Diaz-Buxo JA. Current status of continuous cyclic peritoneal dialysis (CCPD). Petit Dial Int 1989; 9: 9–14.

    CAS  Google Scholar 

  82. Schmidt R, Bender F, Domico J, Bernardini J, Sorkin M, Piraino B. Peritonitis rates of APD may not better those of CAPD. Petit Dial Int 1998; 18 (suppl. 1): S34.

    Google Scholar 

  83. Troidle LK, Gorban-Brennan N, Kliger AS, Finkelstein FO. Continuous cycler therapy, manual peritoneal dialysis therapy, and peritonitis. Adv Petit Dial 1998; 14: 137–41.

    CAS  Google Scholar 

  84. Bird M, Dacko C, Miller M, Bernardini J, Piraino B. Reducing peritonitis in APD patients. Petit Dial Int (In press).

    Google Scholar 

  85. Sewell CM, Clarridge J, Lacke C, Weinman EJ, Young EJ. Staphylococcal nasal carriage and subsequent infection in peritoneal dialysis patients. JAMA 1982; 248: 1493–5.

    Article  PubMed  CAS  Google Scholar 

  86. Luzar MA, Coles GA, Faller B et al. Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis. N Engl J Med 1990; 322: 505–9.

    Article  PubMed  CAS  Google Scholar 

  87. Davies SJ, Ogg CS, Cameron JS, Poston S, Noble WC. Staphylococcus aureus nasal carriage, exit-site infection and catheter loss in patients treated with continuous ambulatory peritoneal dialysis (CAPD). Petit Dial Int 1989; 9: 61–4.

    CAS  Google Scholar 

  88. Piraino B, Perlmutter JA, Holley JL, Bernardini J. Staphylococcus aureus peritonitis is associated with Staphylococcus aureus nasal carriage in peritoneal dialysis patients. Petit Dial Int 1993; 13 (suppl. 2): S332–4.

    Google Scholar 

  89. Wanten GJA, van Oost P, Schneeberger PM, Koolen MI. Nasal carriage and peritonitis by Staphylococcus aureus in patients on continuous ambulatory peritoneal dialysis: a prospective study. Petit Dial Int 1996; 16: 352–6.

    CAS  Google Scholar 

  90. Zimakoff J, Pedersen FB, Bergen Let al. and additional members of the Danish Study Group of Peritonitis in Dialysis (DASPID). Staphylococcus aureus carriage and infections among patients in four haemo-and peritoneal-dialysis centres in Denmark. J Hosp Infect 1996; 33: 289–300.

    Article  PubMed  CAS  Google Scholar 

  91. Kingwatanakul P, Warady BA. Staphylococcus aureus nasal carriage in children receiving long-term peritoneal dialysis. Adv Petit Dial 1997; 13: 281–4.

    CAS  Google Scholar 

  92. Lye WC, Leong SO, van der Straten J, Lee EJC. Staphylococcus aureus CAPD-related infections are associated with nasal carriage. Adv Petit Dial 1994; 10: 163–5.

    CAS  Google Scholar 

  93. Zimmerman SW, O’Brien M, Wiedenhoeft FA, Johnson CA. Staphylococcus aureus peritoneal catheter-related infections: a cause of catheter loss and peritonitis. Petit Dial Int 1988; 8: 191–4.

    Google Scholar 

  94. Vychytil A, Lorenz M, Schneider B, Horl WH, Haag-Weber M. New strategies to prevent Staphylococcus aureus infections in peritoneal dialysis patients. J Am Soc Nephrol 1998; 9: 669–76.

    PubMed  CAS  Google Scholar 

  95. Zimmerman SW, Ahrens E, Johnson CA et al. Randomized controlled trial of prophylactic rifampin for peritoneal dialysis-related infections. Am J Kidney Dis 1991; 18: 225–31.

    PubMed  CAS  Google Scholar 

  96. Perez-Fontan M, Rosales M, Rodriguez-Carmona A et al. Treatment of Staphylococcus aureus nasal carriers in CAPD with mupirocin. Adv Petit Dial 1993; 9: 242–5.

    Google Scholar 

  97. Blowley DL, Warady BA, McFarland KS. The treatment of Staphylococcus aureus nasal carriage in pediatric peritoneal dialysis patients. Adv Petit Dial 1994; 10: 297–9.

    Google Scholar 

  98. Bernardini J, Piraino B, Holley J, Johnston JR, Lutes R. A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2%applied to the exit site versus cyclic oral rifampin. Am J Kidney Dis 1996; 27: 695–700.

    Article  PubMed  CAS  Google Scholar 

  99. Thodis E, Bhaskaran S, Pasadakis P, Bargman JM, Vas SI, Oreopoulos DG. Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site. Petit Dial Int 1998; 18: 261–70.

    CAS  Google Scholar 

  100. Koopmans JG, Boeschoten EW, Pannekeet MM et al. Impaired initial cell reaction in CAPD-related peritonitis. Petit Dial Int 1996; 16 (suppl. 1): S362–7.

    Google Scholar 

  101. Korzets Z, Korzets A, Golan E, Zevin D, Bernheim J. CAPD peritonitis–initial presentation as an acute abdomen with clear peritoneal effluent. Clin Nephrol 1992; 37: 155–7.

    PubMed  CAS  Google Scholar 

  102. Humayan HM, Daugirdas JT, Ing TS, Leehy DJ, Gandhi VC, Popli S. Chylous ascites in a patient treated with intermittent peritoneal dialysis. Artif Organs 1984; 8: 358–60.

    Google Scholar 

  103. Bagnis C, Gabella P, Bruno M et al. Cloudy dialysate due to adenocarcinoma cells in a CAPD patient. Petit Dial Int 1993; 13: 322–3.

    CAS  Google Scholar 

  104. Bargman JM, Zent R, Ellis P, Auger M, Wilson S. Diagnosis of lymphoma in a continuous ambulatory peritoneal dialysis patient by peritoneal fluid cytology. Am J Kidney Dis 1994; 23: 747–50.

    PubMed  CAS  Google Scholar 

  105. Porter J, Wang WM, Oliveira DBG. Chylous ascites and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1991; 6: 659–61.

    Article  PubMed  CAS  Google Scholar 

  106. Kim D, Tapson J, Wu G, Khanna R, Vas SI, Oreopoulos DG. Staph aureus peritonitis in patients on continuous ambulatory peritoneal dialysis. Trans Am Soc Artif Intern Organs 1984; 30: 494–7.

    PubMed  CAS  Google Scholar 

  107. De Bustillo EM, Aguilera A, Jimenez C, Bajo MA, Sanchez C, Selegas R. Streptococcal versus Staphylococcus epidermidis peritonitis in CAPD. A comparative study. Petit Dial Int 1997; 17: 392–5.

    Google Scholar 

  108. Wakeen MJ, Zimmerman SW, Bidwell D. Viscus perforation in peritoneal dialysis patients: diagnosis and outcome. Petit Dial Int 1994; 14: 371–7.

    CAS  Google Scholar 

  109. Chang JJ, Yeun JY, Harsbargen JA. Pneumoperitoneum in peritoneal dialysis patients. Am J Kidney Dis 1995; 25; 297–301.

    Article  PubMed  CAS  Google Scholar 

  110. Plum J, Sudkamp S, Grabensee B. Results of ultrasound-assisted diagnosis of tunnel infections in continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1994; 23: 99–104.

    PubMed  CAS  Google Scholar 

  111. Keane WF, Peterson PK. Peritonitis during continuous ambulatory peritoneal dialysis: the role of host defense mechanisms. Trans Am Soc Artif Intern Organs 1984; 30: 684–6.

    PubMed  CAS  Google Scholar 

  112. Flanigan MJ, Freeman RM, Lim VS. Cellular response to peritonitis among peritoneal dialysis patients. Am J Kidney Dis 1985; 6: 420–4.

    PubMed  CAS  Google Scholar 

  113. Riera G, Bushinsky D, Emmanouel DS. First exchange neutrophilia: an index of peritonitis during chronic intermittent peritoneal dialysis. Clin Nephrol 1985; 24: 5–8.

    PubMed  CAS  Google Scholar 

  114. Smoszna J, Raczka A, Fuksiewicz A, Wankowicz Z. Prognostic value of different tests in the early diagnosis of peritonitis during standard peritoneal dialysis (SPD). Adv Petit Dial 1988; 4: 194–7.

    Google Scholar 

  115. Antonsen S, Pedersen FB, Wang P, and the Danish Study Group on Peritonitis in Dialysis (DASPID). Leukocytes in peritoneal dialysis effluents. Petit Dial Int 1991; 11: 43–7.

    Google Scholar 

  116. Holley HP, Tucker CT, Moffatt TL, Dodds KA, Dodds HM. Tuberculous peritonitis in patients undergoing chronic home peritoneal dialysis. Am J Kidney Dis 1982; 1: 222–6.

    PubMed  Google Scholar 

  117. Mallat SG, Brensilver JM. Tuberculous peritonitis in a CAPD patient cured without catheter removal: case report, review of the literature and guidelines for treatment and diagnosis. Am J Kidney Dis 1989; 13: 154–7.

    PubMed  CAS  Google Scholar 

  118. Dunmire RB, Breyer JA. Nontuberculous mycobacterial peritonitis during continuous ambulatory peritoneal dialysis: case report and review of diagnostic and therapeutic strategies. Am J Kidney Dis 1991; 18: 126–30.

    PubMed  Google Scholar 

  119. Sridhar R, Thornely-Brown D, Kant KS. Peritonitis due to Aspergillus niger: diagnostic importance of peritoneal eosinophilia. Petit Dial Int 1990; 10: 100–1.

    CAS  Google Scholar 

  120. Nankivell BJ, Pacey D, Gordon DL. Peritoneal eosinophilia associated with Paecilomyces variotii infection in continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1991; 18: 603–5.

    PubMed  CAS  Google Scholar 

  121. Gokal R, Ramos JM, Ward MK, Kerr DNS. `Eosinophilic’ peritonitis in continuous ambulatory peritoneal dialysis (CAPD). Clin Nephrol 1981; 15: 328–30.

    PubMed  CAS  Google Scholar 

  122. Solary E, Cabanne JF, Tanter Y, Rifle G. Evidence for a role of plasticizers in `eosinophilic’ peritonitis in continuous ambulatory peritoneal dialysis. Nephron 1986; 42: 341–2.

    Article  PubMed  CAS  Google Scholar 

  123. Piraino BM, Silver MR, Dominguez JH, Puschett JB. Peritoneal eosinophils during intermittent peritoneal dialysis. Am J Nephrol 1984; 4: 152–7.

    Article  PubMed  CAS  Google Scholar 

  124. Chandran PKG, Humayun HM, Daugirdas JT, Nawab ZM, Gandhi VC, Ing TS. Blood eosinophila in patients undergoing maintenance peritoneal dialysis. Arch Intern Med 1985; 145: 114–16.

    Article  PubMed  CAS  Google Scholar 

  125. Chan MK, Chow L, Lam SS, Jones B. Peritoneal eosinophilia in patients on continuous ambulatory peritoneal dialysis: a prospective study. Am J Kidney Dis 1988; 11: 180–3.

    PubMed  CAS  Google Scholar 

  126. Nassberger L, Arbin A. Eosinophic peritonitis–hypothesis. Nephron 1987; 46: 103–4.

    Article  PubMed  CAS  Google Scholar 

  127. Leung ACT, Orange G, Henderson IS. Intraperitoneal hydrocortisone in eosinophilic peritonitis associated with continuous ambulatory peritoneal dialysis. Br Med J 1983; 286: 766.

    Article  CAS  Google Scholar 

  128. Tang S, Lo CY, Lo WK, Chan TM. Resolution of eosinophilic peritonitis with ketotifen. Am J Kidney Dis 1997; 30: 433–6.

    Article  PubMed  CAS  Google Scholar 

  129. Ryan S, Fessia S. Improved method for recovery of peritonitis-causing microorganisms from peritoneal dialysate. J Clin Microbiol 1987; 25: 383–4.

    PubMed  CAS  Google Scholar 

  130. Luce E, Nakagawa D, Lovell J, Davis J, Stinebaugh BJ, Suki WN. Improvement in the bacteriologic diagnosis of peritonitis with the use of blood culture media. Trans Am Soc Artif Intern Organs 1982; 28: 259–62.

    PubMed  CAS  Google Scholar 

  131. Blondeau JM, Pylypchuk GB, Kappel JE, Pilkey B, Lawler C. Comparison of bedside-and laboratory-inoculated Bactec high-and low-volume resin bottles for the recovery of microorganisms causing peritonitis in CAPD patients. Diagn Microbiol Infect Dis 1998; 31: 281–7.

    Article  PubMed  CAS  Google Scholar 

  132. McIntyre M, Trend V, Depoiy C. The microbiological diagnosis of CAPD peritonitis. Petit Dial Bull 1986; 6: 40–1.

    Google Scholar 

  133. Lye WC, Wong PL, Leong SO, Lee EJC. Isolation of organisms in CAPD peritonitis: a comparison of two techniques. Adv Petit Dial 1994; 10: 166–8.

    CAS  Google Scholar 

  134. Sewell DL, Golper TA, Hulman PB et al. Comparison of large volume culture to other methods for isolation of microorganisms from dialysate. Petit Dial Int 1990; 10: 49–52.

    CAS  Google Scholar 

  135. Forbes BA, Frymoyer PA, Kopecky RT, Wojtaszek JM, Pettit DJ. Evaluation of the lysis-centrifugation system for culturing dialysates from continuous ambulatory peritoneal dialysis patients with peritonitis. Am J Kidney Dis 1988; 11: 176–9.

    PubMed  CAS  Google Scholar 

  136. Fenton P. Laboratory diagnosis of peritonitis in patients undergoing continuous ambulatory peritoneal dialysis. J Clin Pathol 1982; 35: 1181–4.

    Article  PubMed  CAS  Google Scholar 

  137. Bezerra DA, Silva MB, Caramori JST et al. The diagnostic value of gram stain for initial identification of the etiologic agent of peritonitis in CAPD patients. Petit Dial Int 1997; 17: 269–72.

    CAS  Google Scholar 

  138. Korzets Z, Erdberg A, Golan E et al. Frequent involvement of the internal cuff segment in CAPD peritonitis and exit-site infection–an ultrasound study. Nephrol Dial Transplant 1996; 11: 336–9.

    Article  PubMed  CAS  Google Scholar 

  139. Vychytil A, Lorenz M, Schneider B, Horl WH, Haag-Weber M. New criteria for management of catheter infec-tions in peritoneal dialysis patients using ultrasonography. J Am Soc Nephrol 1998; 9: 290–6.

    PubMed  CAS  Google Scholar 

  140. Holley JL, Foulks CJ, Moss AH, Willard D. Ultrasound as a tool in the diagnosis and management of exit-site infection in patients undergoing continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1989; 14: 211–16.

    PubMed  CAS  Google Scholar 

  141. Domico J, Warman M, Jaykamur S, Sorkin MI. Is ultrasonography useful in predicting catheter loss? Adv Petit Dial 1993; 9: 231–2.

    CAS  Google Scholar 

  142. Keane WF, Alexander SR, Bailie GR et al. Peritoneal dialysis-related peritonitis treatment recommendations: 1996 update. Petit Dial Int 1996; 16: 557–73.

    CAS  Google Scholar 

  143. Bunke M, Brier M, Golper TA. Culture-negative CAPD peritonitis: the Network 9 Study. Adv Petit Dial 1994; 10: 174–8.

    CAS  Google Scholar 

  144. Holley JL, Moss AH. A prospective evaluation of blood culture versus standard plate techniques for diagnosing peritonitis in continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1989; 13: 184–8.

    PubMed  CAS  Google Scholar 

  145. Eisele G, Adewunni C, Bailie GR, Yocum D, Venezia R. Surreptitious use of antimicrobial agents by CAPD patients. Petit Dial Int 1993; 13: 313–15.

    CAS  Google Scholar 

  146. Pagniez DC, Vrtovsnik F, Delvallez L, Reade R, Dequiedt P, Tacquet A. Ofloxacin treatment may mask tuberculous peritonitis in CAPD patients. Perit Dial Int 1991; 11: 92–3.

    PubMed  CAS  Google Scholar 

  147. Burkhart J, Haigler S, Caruana R, Hylander B. Usefulness of peritoneal fluid amyalse levels in the differential of peritonitis in peritoneal dialysis patients. J Am Soc Nephrol 1991; 1: 1186–90.

    Google Scholar 

  148. Caruana RJ, Burkhart J, Segraves D, Smallwood S, Haymore J, Disher B. Serum and peritoneal fluid amylase levels in CAPD. Am J Nephrol 1987; 7: 169–72.

    Article  PubMed  CAS  Google Scholar 

  149. Charney DI, Gouge SF. Chemical peritonitis secondary to intraperitoneal vancomycin. Am J Kidney Dis 1991; 17: 76–9.

    PubMed  CAS  Google Scholar 

  150. Piraino B, Bernardini J, Johnston J et al. Chemical peritonitis due to intraperitoneal vancomycin (Vancoled). Petit Dial Bull 1987; 7: 156–9.

    Google Scholar 

  151. Wong PN, Mak SK, Lee KF, Fung LH, Wong AKM. A prospective study of vancomycin- (Vancoled-)induced chemical peritonitis in CAPD patients. Petit Dial Int 1997; 17: 202–4.

    CAS  Google Scholar 

  152. Karanicolas S, Oreopoulos DG, Izatt SH et al. Epidemic of aseptic peritonitis caused by endotoxin during chronic peritoneal dialysis. N Engl J Med 1977; 296: 1336–7.

    Article  PubMed  CAS  Google Scholar 

  153. Nankivell BJ, Lake N, Gillies A. Intracatheter streptokinase for recurrent peritonitis in CAPD. Clin Nephrol 1991; 35: 20–3.

    PubMed  CAS  Google Scholar 

  154. Coronet F, Martin-Rabadan P, Romero J. Chemical peritonitis after intraperitoneal administration of amphotericin B in a fungal infection of the catheter subcutaneous tunnel. Petit Dial Int 1993; 13: 161–2.

    Google Scholar 

  155. Bennett-Jones D, Wass V, Mawson P et al. A comparison of intraperitoneal and intravenous/oral antibiotics in CAPD peritonitis. Petit Dial Bull 1987; 7: 31–3.

    Google Scholar 

  156. Keane WF, Everett ED, Golper TA et al. Peritoneal dialysis-related peritonitis treatment recommendations: 1993 update. Petit Dial Int 1993; 13: 14–28.

    CAS  Google Scholar 

  157. Nikolaidis P, Walker SE, Dombros N, Toourkantonis A, Paton TW, Oreopoulos DG. Single-dose pefloxacin pharmacokinetics and metabolism in patients undergoing continuous ambulatory peritoneal dialysis (CAPD). Petit Dial Int 1991; 11: 59–63.

    CAS  Google Scholar 

  158. Janknegt R. CAPD peritonitis and fluoroquinolones. Petit Dial Int 1991; 11: 48–58.

    CAS  Google Scholar 

  159. Cheng IKP, Chan CY, Wong WT et al. A randomized prospective comparison of oral versus intraperitoneal ciprofloxacin as the primary treatment of peritonitis complicating continuous ambulatory peritoneal dialysis. Petit Dial Int 1993; 13 (suppl. 2): 5351–4.

    Google Scholar 

  160. Perez-Fontan M, Rosales M, Fernandez F et al. Ciprofloxacin in the treatment of gram-positive bacterial peritonitis in patients undergoing CAPD. Petit Dial Int 1991; 11: 233–6.

    CAS  Google Scholar 

  161. Weber J, Staerz E, Mettang T, Machleidt C, Kuhlmann U. Treatment of peritonitis continuous ambulatory peritoneal dialysis (CAPD) with intraperitoneal cefazolin and gentamicin. Petit Dial Int 1989; 9: 191–5.

    CAS  Google Scholar 

  162. Vas S, Bargman J, Oreopoulos DG. Treatment of PD patients of peritonitis caused by gram-positive organisms with single daily dose of antibiotics. Petit Dial Int 1997; 17: 91–4.

    CAS  Google Scholar 

  163. Lupo A, Rugiu C, Bernich P et al. A prospective, randomized trial of two antibiotic regimens in the treatment of peritonitis in CAPD patients: teicoplanin plus tobramycin versus cephalothin plus tobramycin. J Antimicrob Chemother 1997; 40: 729–32.

    Article  PubMed  CAS  Google Scholar 

  164. Golper T. Intermittent versus continuous antibiotics for PD-related peritonitis. Petit Dial Int 1997; 17: 11–12.

    CAS  Google Scholar 

  165. Thomas JK, Forrest A, Bhavnani SM et al. Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy. Antimicrob Agents Chemother 1998; 42: 521–7.

    PubMed  CAS  Google Scholar 

  166. Gucek A, Bren AF, Lindic J, Hergouth V, Mlinsek D. Is monotherapy with cefazolin of ofloxacin an adequate treatment for peritonitis in CAPD patients? Adv Petit Dial 1994; 10: 144–6.

    CAS  Google Scholar 

  167. Lai MN, Kao MT, Chen CC, Cheung SY, Chung WK. Intraperitoneal once-daily dose of cefazolin and gentamycin for treating CAPD peritonitis. Petit Dial Int 1997; 17: 87–9.

    CAS  Google Scholar 

  168. Flanigan MJ, Lim VS. Initial treatment of dialysis associated peritonitis: a controlled trial of vancomycin versus cefazolin. Petit Dial Int 1991; 11: 31–7.

    CAS  Google Scholar 

  169. Gucek A, Bren AF, Hergouth V, Lindic J. Cefazolin and netilmycin versus vancomycin and ceftazidime in the treatment of CAPD peritonitis. Adv Petit Dial 1997; 13: 218–20.

    CAS  Google Scholar 

  170. Nikolaidis PP. Quinolones: pharmacokinetics and pharmacodynamics. Petit Dial Int 1993; 13 (suppl. 2): S377–9.

    Google Scholar 

  171. Cheng IKP, Chan CY, Wong WT. A randomised prospective comparison of oral ofloxacin and intraperitoneal vancomycin plus aztreonam in the treatment of bacterial peritonitis complicating continuous ambulatory peritoneal dialysis (CAPD). Petit Dial Int 1991; 11: 27–30.

    CAS  Google Scholar 

  172. Nye KJ, Gibson SP, Nwosu AC, Manji MR, Robinson BHB, Hawkins JB. Single-dose intraperitoneal vancomycin and oral ciprofloxacin for the treatment of peritonitis in CAPD patients: preliminary report. Petit Dial Int 1993; 13: 59–60.

    CAS  Google Scholar 

  173. Piraino B, Bernardini J, Sorkin M. A five year study of the microbiologic results of exit site infections and peritonitis in continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1987; 10: 281–6.

    PubMed  CAS  Google Scholar 

  174. Keller E. Pharmacokinetics and pharmacodynamics of anti-staphylococcal antibiotics in continuous ambulatory peritoneal dialysis patients. Petit Dial Int 1993; 13 (suppl. 2): S367–70.

    Google Scholar 

  175. Lye WC, Leong SO, Lee EJC. Methicillin-resistant Staphylococcus aureus nasal carriage and infections in CAPD. Kidney Int 1993; 43: 1357–62.

    Article  PubMed  CAS  Google Scholar 

  176. Borra SI, Chandarana J, Kleinfeld M. Fatal peritonitis due to Group B 13-hemolytic Streptococcus in a patient receiving continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1992; 19: 375–7.

    PubMed  CAS  Google Scholar 

  177. Suh H, Wadhwa NK, Cabralda T, Sorrento J. Endogenous peritonitis and related outcome in peritoneal dialysis patients. Adv Petit Dial 1996; 12: 192–5.

    CAS  Google Scholar 

  178. Low CL, Eisele G, Cerda J et al. Low prevalence of vancomycin-resistant Enterococcus in dialysis outpatients with a history of vancomycin use. Petit Dial Int 1996; 16: 651–2.

    CAS  Google Scholar 

  179. Sandoe JAT, Gokal R, Struthers JK. Vancomycin-resistant enterococci and empirical vancomycin for CAPD peritonitis. Petit Dial Int 1997; 17: 617–18.

    CAS  Google Scholar 

  180. Brady JP, Snyder JW, Harsbargen JA. Vancomycin-resistant Enterococcus in end-stage renal disease. Am J Kidney Dis 1998; 32: 415–18.

    Article  PubMed  CAS  Google Scholar 

  181. Tokars JI, Miller ER, Alter MJ, Arduino MJ. National surveillance of dialysis associated diseases in the United States, 1995. ASAIO J 1998; 44: 98–107.

    Article  PubMed  CAS  Google Scholar 

  182. Troidle LK, Kliger AS, Gorban-Brennan N, Fikrig M, Golden M, Finkelstein FO. Nine episodes of CPD-associated peritonitis with vancomycin resistant enterococci. Kidney Int 1996; 50: 1368–72.

    Article  PubMed  CAS  Google Scholar 

  183. Lynn WA, Clutterbuck E, Want S et al. Treatment of CAPDperitonitis due to glycopeptide-resistant Enterococcus faecium with quinupristin/dalfopristin. Lancet 1994; 344: 1025–26.

    Article  PubMed  CAS  Google Scholar 

  184. Linden PK, Pasculle AW, McDevitt D, Kramer DJ. Effect of quinupristin/dalfopristin on the outcome of vancomycinresistant Enterococcus faecium bacteraemia: comparison with a control cohort. J Antimicrob Chemother 1997; 39 (suppl. A): 1–7.

    Article  Google Scholar 

  185. Norris AH, Reilly JP, Edelstein PH, Brennan PJ, Schuster MG. Chloramphenicol for the treatment of vancomycinresistant enterococcal infections. Clin Infect Dis 1995; 20: 1137–44.

    Article  PubMed  CAS  Google Scholar 

  186. Hiramatsu K, Aritaka N, Hanaki H et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 1997; 350: 1670–3.

    Article  PubMed  CAS  Google Scholar 

  187. Ploy MC, Gelaud C, martin C, de Lumley L, Denis T. First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital. Lancet 1998; 351: 1212.

    Article  PubMed  CAS  Google Scholar 

  188. CDC Update - Staphylococcus aureus with reduced susceptibility to vancomycin - United States, 1997. MMWR 1997; 46: 813.

    Google Scholar 

  189. Chong TK, Piraino B, Bernardini J. Vestibular toxicity due to gentamicin in peritoneal dialysis patients. Petit Dial Trans 1991; 11: 152–5.

    CAS  Google Scholar 

  190. Lee J, Innes CP, Petyo CM. Vertigo in CAPD patients treated with intraperitoneal gentamicin. Petit Dial Int 1989; 9: no. 97.

    Google Scholar 

  191. Kahlmeter G, Dahlager JI Aminoglycoside toxicity–a review of clinical studies published between 1975 and 1982. J Antimicrob Chemother 1984; 13 (suppl. A): 9–22.

    Article  PubMed  Google Scholar 

  192. Gendeh BS, Said H, Gibb AG, Aziz NS, Kong N, Zahir ZM. Gentamicin ototoxicity in continuous ambulatory peritoneal dialysis. J Laryngol Oto 1993; 107: 681–5.

    Article  CAS  Google Scholar 

  193. Nikolaidis P, Vas S, Lawson V et al. Is intraperitoneal tobramycin ototoxic in CAPD patients? Petit Dial Int 1991; 11: 156–61.

    CAS  Google Scholar 

  194. Spencer RC. Infections in continuous ambulatory peritoneal dialysis. J Med Microbiol 1988; 27: 1–9.

    Article  PubMed  CAS  Google Scholar 

  195. Beaman M, Solaro L, McGonigle RSJ, Michael J, Adu D. Vancomycin and ceftazidime in the treatment of CAPD peritonitis. Nephron 1989; 51: 51–5.

    Article  PubMed  CAS  Google Scholar 

  196. Gray HH, Goulding S, Eykyn SJ. Intraperitoneal vancomycin and ceftazidime in the treatment of CAPD peritonitis. Clin Nephrol 1985; 23: 81–4.

    PubMed  CAS  Google Scholar 

  197. Shemin D, Maaz D. Gram-negative peritonitis in peritoneal dialysis: improved outcome with intraperitoneal ceftazidime. Petit Dial Int 1996; 16: 638–41.

    CAS  Google Scholar 

  198. Lye WC, Lee EJC, Leong SO, Kumarasinghe G. Clinical characteristics and outcome of Acinetobacter infections in CAPD patients. Petit Dial Int 1994; 14: 174–7.

    CAS  Google Scholar 

  199. Ruiz A, Ramos B, Burgos D, Frutos MA, de Novales EL. Acinetobacter calcoaceticus peritonitis in continuous ambulatory peritoneal dialysis (CAPD) patients. Petit Dial Int 1988; 8: 285–6.

    Google Scholar 

  200. Szeto CC, Li PKT, Leung CB et al. Xanthomonas maltophilia peritonitis in uremic patients receiving continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1997; 29: 91–5.

    Article  PubMed  CAS  Google Scholar 

  201. Spence PA, Mathews RE, Khanna R, Oreopoulos D. Indications for operation when peritonitis occurs in patients oncontinuous ambulatory peritoneal dialysis. Surg Gynecol Obstet 1985; 161: 450–2.

    PubMed  CAS  Google Scholar 

  202. Miller GV, Bhandari S, Brownjohn AM, Turney JH, Benson EA. `Surgical’ peritonitis in the CAPD patient. Ann R Coll Surg Engl 1998; 80; 36–9.

    PubMed  CAS  Google Scholar 

  203. Morduchowicz G, van Dyk DJ, Wittenberg C, Winkler J, Boner G. Bacteremia complicating peritonitis in peritoneal dialysis patients. Am J Nephrol 1993; 13: 278–80.

    Article  PubMed  CAS  Google Scholar 

  204. Bunke M, Brier ME, Golper TA representing the Academic Committee of Network #9. Pseudomonas peritonitis in peritoneal dialysis patients: the Network #9 Peritonitis Study. Am J Kidney Dis 1995; 25: 769–74.

    Article  PubMed  CAS  Google Scholar 

  205. Krothapalli R, Duffy WB, Lacke C et al. Pseudomonas peritonitis and continuous ambulatory peritoneal dialysis. Arch Intern Med 1982; 142: 1862–3.

    Article  PubMed  CAS  Google Scholar 

  206. Kazmi HR, Raffone FD, Kliger AS, Finkelstein FO. Pseudomonas exit site infections in continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol 1992; 2: 1498–501.

    PubMed  CAS  Google Scholar 

  207. Montane BS, Mazza I, Abitbol C et al. Fungal peritonitis in pediatric patients. Adv Petit Dial 1998; 14: 251–4.

    CAS  Google Scholar 

  208. Rubin J, Kirchner K, Walsh D, Green M, Bower J. Fungal peritonitis during continuous ambulatory peritoneal dialysis: a report of 17 cases. Am J Kidney Dis 1987; 10: 361–8.

    PubMed  CAS  Google Scholar 

  209. Chan TM, Chan CY, Cheng SW, Lo WK, Lo CY, Cheng IPK. Treatment of fungal peritonitis complicating continuous ambulatory peritoneal dialysis with oral fluconazole: a series of 21 patients. Nephrol Dial Transplant 1994; 9: 539–42.

    PubMed  CAS  Google Scholar 

  210. Hoch BS, Namboodiri NK, Banayat G et al. The use of fluconazole in the management of Candida peritonitis in patients on peritoneal dialysis. Petit Dial Int 1993; 13 (suppl. 2): S357–9.

    Google Scholar 

  211. Montengro J, Aguirre R, Gonzalez 0, Martinez I, Saracho R. Fluconazole treatment of Candida peritonitis with delayed removal of the peritoneal dialysis catheter. Clin Nephrol 1995; 44: 60–3.

    Google Scholar 

  212. Oh SH, Conley SB, Rose GM, Rosenblum M, Kohl S, Pickering LK. Fungal peritonitis in children undergoing peritoneal dialysis. Pediatr Infect Dis 1985; 4: 62–6.

    Article  PubMed  CAS  Google Scholar 

  213. Vargemezis V, Papadopoulou ZL, Liamos H et al. Management of fungal peritonitis during continuous ambulatory peritoneal dialysis (CAPD). Petit Dial Bull 1986; 6: 17–20.

    Google Scholar 

  214. Fabris A, Pellanda MV, Gardin C, Contestabile A, Bolzonella R. Pharmacokinetics of antifungal agents. Petit Dial Int 1993; 13 (suppl. 2): S380–2.

    Google Scholar 

  215. Debruyne D, Ryckelynck JP Fluconazole serum, urine, and dialysate levels in CAPD patients. Petit Dial Int 1992; 12: 328–9.

    CAS  Google Scholar 

  216. Benevent D, Peyronnet P, Lagarde C, Lerouz-Robert C. Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: three recoveries in five cases without catheter removal. Nephron 1985; 41: 203–6.

    Article  PubMed  CAS  Google Scholar 

  217. Nagappan R, Collins JF, Lee WT. Fungal peritonitis in continuous ambulatory peritoneal dialysis–the Auckland experience. Am J Kidney Dis 1992; 20: 492–6.

    PubMed  CAS  Google Scholar 

  218. Cheng IKP, Chan PCK, Chan MK. Tuberculous peritonitis complicating long-term peritoneal dialysis. Am J Nephrol 1989; 9: 155–61.

    Article  PubMed  CAS  Google Scholar 

  219. White R, Abreo K, Flanagan R et al. Nontuberculous mycobacterial infections in continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis 1993; 22: 581–7.

    PubMed  CAS  Google Scholar 

  220. Smith JL, Flanigan MJ. Peritoneal dialysis catheter sepsis: a medical and surgical dilemma. Am J Surg 1987; 154: 602–7.

    Article  PubMed  CAS  Google Scholar 

  221. Gokal R, Ash SR, Helfrich GB et al. Peritoneal catheters and exit-site practices: toward optimum peritoneal access. Perit Dial Int 1993; 13: 29–39.

    PubMed  CAS  Google Scholar 

  222. Schroder CH, Severijnen RSVM, de Jong MCW, Monnens LAH. Chronic tunnel infections in children: removal and replacement of the continuous ambulatory peritoneal dialysis catheter in a single operation. Petit Dial Int 1993; 13: 198–200.

    CAS  Google Scholar 

  223. Swartz R, Messana J, Reynolds J, Ranjit U. Simultaneous catheter replacement and removal in refractory peritoneal dialysis infections. Kidney Int 1991; 40: 1160–5.

    Article  PubMed  CAS  Google Scholar 

  224. Majkowski NL, Mendley SR. Simultaneous removal and replacement of infected peritoneal dialysis catheters. Am J Kidney Dis 1997; 29: 706–11.

    Article  PubMed  CAS  Google Scholar 

  225. Cancarini GC, Manili L, Brunori G et al. Simultaneous catheter replacement-removal during infectious complications in peritoneal dialysis. Adv Petit Dial 1994; 10: 210–13.

    CAS  Google Scholar 

  226. Fredensborg BB, Meyer HW, Joffe P, Fugleberg S. Reinsertion of PD catheters during PD-related infections performed either simultaneously or after an intervening period. Petit Dial Int 1995; 15: 374–8.

    CAS  Google Scholar 

  227. Goldraich I, Mariano M, Rosito N, Goldraich N. One-step peritoneal catheter replacement in children. Adv Petit Dial 1993; 9: 325–8.

    CAS  Google Scholar 

  228. Posthuma N, Borgstein PJ, Eijsbouts Q, ter Wee PM. Simultaneous peritoneal dialysis catheter insertion and removal in catheter-related infections without interruption of peritoneal dialysis. Nephrol Dial Transplant 1998; 13: 700–3.

    Article  PubMed  CAS  Google Scholar 

  229. Mayo RR, Messana JM, Boyer CJ, Swartz RD. Pseudomonas peritonitis treated with simultaneous catheter replacement and removal. Petit Dial Int 1995; 15: 389–90.

    CAS  Google Scholar 

  230. Mulhern JG, Braden GL, O’Shea MH, Madden RL, Lipkowitz GS, Germain MJ. Trough serum vancomycin levels predict the relapse of gram-positive peritonitis in peritoneal dialysis patients. Am J Kidney Dis 1995; 25: 611–15.

    Article  PubMed  CAS  Google Scholar 

  231. Dasgupta MK. Use of streptokinase or urokinase in recurrent CAPD peritonitis. Adv Petit Dial 1991; 7: 169–72.

    CAS  Google Scholar 

  232. Murphy G, Tzamaloukas AH, Eisenberg B, Gibel LJ, Avasthi PS. Intraperitoneal thrombolytic agents in relapsing or persistent peritonitis of patients on continuous ambulatory peritoneal dialysis. Int J Artif Organs 1991; 14: 87–91.

    PubMed  CAS  Google Scholar 

  233. Williams AJ, Boletis I, Johnson BF et al. Tenckhoff catheter replacement or intraperitoneal urokinase: a randomised trial in the management of recurrent continuous ambulatory peritoneal dialysis (CAPD) peritonitis. Petit Dial Int 1989; 9: 65–7.

    CAS  Google Scholar 

  234. Innes A, Burden RP, Finch RG, Morgan AG. Treatment of resistant peritonitis in continuous ambulatory peritoneal dialysis with intraperitoneal urokinase: a double-blind clinical trial. Nephrol Dial Transplant 1994; 9: 797–9.

    PubMed  CAS  Google Scholar 

  235. Golper TA, Hartstein AI. Analysis of the causative pathogens in uncomplicated CAPD-associated peritonitis: duration of therapy, relapses and prognosis. Am J Kidney Dis 1986; 7: 141–5.

    PubMed  CAS  Google Scholar 

  236. Khanna R, Wu G, Vas S, Oreopoulos DG. Mortality and morbidity on continuous ambulatory peritoneal dialysis. ASAIO J 1983; 6: 197–204.

    Google Scholar 

  237. Heaton A, Rodger RSC, Sellars L et al. Continuous ambulatory peritoneal dialysis after the honeymoon: review of experience in Newcastle 1979–1984. Br Med J 1986; 293: 938–41.

    Article  CAS  Google Scholar 

  238. Boroujerdi-Rad H, Juergensen P, Mansourian V, Kliger AS, Finkelstein FO. Abdominal abscesses complicating peritonitis in continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis 1994; 23: 717–21.

    PubMed  CAS  Google Scholar 

  239. Maiorca R, Cancarini GC, Zubani R et al. CAPD viability: a long-term comparison with hemodialysis. Petit Dial Int 1996; 16: 276–87.

    CAS  Google Scholar 

  240. Fox L, Tzamaloukas AH, Murata GH. Metabolic differences between persistent and routine peritonitis in CAPD. Adv Petit Dial 1992; 8: 346–50.

    CAS  Google Scholar 

  241. Hendriks PMEM, Ho-dac-Pannekeet MM, van Gulik TM et al. Peritoneal sclerosis in continuous peritoneal dialysis patients: analysis of clinical presentation, risk factors, and peritoneal transport kinetics. Petit Dial Int 1997; 17: 136–43.

    CAS  Google Scholar 

  242. Nomoto Y, Kawaguchi Y, Kubo H, Hirano H, Sakai S, Kurokawa K. Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: a report of the Japanese encapsulating peritonitis study group. Am J Kidney Dis 1996; 28: 420–7.

    Article  PubMed  CAS  Google Scholar 

  243. Dobbie JW, Henderson I, Wilson LS. New evidence on the pathogenesis of sclerosing encapsulating peritonitis (SEP) obtained from serial biopsies. Adv Petit Dial 1987; 3: 138–49.

    Google Scholar 

  244. Dobbie JW. Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis. Petit Dial Int 1992; 12: 14–27.

    CAS  Google Scholar 

  245. Davies SJ, Bryan J, Phillips L, Russell GI. Longitudinal changes in peritoneal kinetics: the effect of dialysis and peritonitis. Nephrol Dial Transplant 1996; 11: 498–506.

    Article  PubMed  CAS  Google Scholar 

  246. Tzamaloukas AH. Decreasing morbidity and mortality in long-term peritoneal dialysis patients. Semin Dial 1995; 8: 397–400.

    Article  Google Scholar 

  247. Dryden MS, Ludlam HA, Wing AJ, Phillips J. Active intervention dramatically reduces CAPD-associated infection. Adv Petit Dial 1991; 7: 125–8.

    CAS  Google Scholar 

  248. Oreopoulos DG, Vas SI, Khanna R. Prevention of peritonitis during continuous ambulatory peritoneal dialysis. Petit Dial Bull 1983; 3 (suppl.) S18–22.

    Google Scholar 

  249. Dabbagh S, Fassinger N, Clement K, Fleishman LE. The effect of aggressive nutrition on infection rates in patients maintained on peritoneal dialysis. Adv Petit Dial 1991; 7: 161–4.

    CAS  Google Scholar 

  250. Miller TE, Findon G. Touch contamination of connection devices in peritoneal dialysis–a quantitative microbiologic analysis. Petit Dial Int 1997; 17: 560–7.

    CAS  Google Scholar 

  251. Joh J, Padmanabhan K, Bastani B. Pasteurella multocida peritonitis following cat bite of peritoneal dialysis tubing. With a brief review of the literature. Am J Nephrol 1998; 18: 258–9.

    Article  PubMed  CAS  Google Scholar 

  252. Mackay K, Brown L, Hudson K. Pasteurella multocida peritonitis in peritoneal dialysis patients: beware of the cat. Petit Dial Int 1997; 17: 608–10.

    CAS  Google Scholar 

  253. Gokal R, Alexander S, Ash S et al. Peritoneal catheters and exit-site practices toward optimum peritoneal access: 1998 update. Petit Dial Int 1998; 18: 11–33.

    CAS  Google Scholar 

  254. Wikdahl AM, Engman U, Stemayr BG, Sorensen JG. One-dose cefuroxime IV and IP reduces microbial growth in PD patients after catheter insertion. Nephrol Dial Transplant 1997; 12: 157–60.

    Article  PubMed  CAS  Google Scholar 

  255. Bennett-Jones DN, Martin J, Barratt AJ, Duffy TJ, Naish PF, Aber GM. Prophylactic gentamicin in the prevention of early exit-site infections and peritonitis in CAPD. Adv Petit Dial 1988; 4: 147–50.

    Google Scholar 

  256. Lye WC, Lee EJC, Tan CC. Prophylactic antibiotics in the insertion of Tenckhoff catheters. Scand J Urol Nephrol 1992; 26: 177–80.

    PubMed  CAS  Google Scholar 

  257. Sardegna KM, Beck AM, Strife CF. Evaluation of perioperative antibiotics at the time of dialysis catheter placement. Pediatr Nephrol 1998; 12: 149–52.

    Article  PubMed  CAS  Google Scholar 

  258. The Mupirocin Study Group. Nasal mupirocin prevents Staphylococcus aureus exit-site infection during peritoneal dialysis. J Am Soc Nephrol 1996; 7: 2403–8.

    Google Scholar 

  259. Hanevold CD, Fisher MC, Waltz R, Bartosh S, Baluarte HJ. Effect of rifampin on Staphylococcus aureus colonization in children on peritoneal dialysis. Pediatr Nephrol 1995; 9: 609–11.

    Article  PubMed  CAS  Google Scholar 

  260. Rao SP, Oreopoulos DG. Unusual complication of polyurethane PD catheter. Petit Dial Int 1997; 17: 410–12.

    CAS  Google Scholar 

  261. Slocombe B, Perry C. The antimicrobial activity of mupirocin–an update on resistance. J Hosp Infect 1991; 19 (suppl. B): 19–25.

    Article  PubMed  Google Scholar 

  262. Kauffman CA, Terpenning MS, He X et al. Attempts to eradicate methicillin-resistant Staphylococcus aureus from a long-term-care facility with the use of mupirocin ointment. Am J Med 1993; 94: 371–8.

    Article  PubMed  CAS  Google Scholar 

  263. Lo WK, Chen CY, Cheng SW, Poon JFM, Chan DTM, Cheng IKP. A prospective randomized control study of nystatin prophylaxis for Candida complicating continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1996; 28: 549–52.

    Article  PubMed  CAS  Google Scholar 

  264. Wadhwa NK, Suh H, Cabralda T. Antifungal prophylaxis for secondary fungal peritonitis in peritoneal dialysis patients. Adv Perit Dial 1996; 12: 189–91.

    PubMed  CAS  Google Scholar 

  265. Zaruba K, Peters J, Jungbluth H. Successful prophylaxis for fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: six years’ experience Am J Kidney Dis 1991; 17: 43–6.

    CAS  Google Scholar 

  266. Robitaille P, Merouani A, Clermont MJ, Hebert E. Successful antifungal prophylaxis in chronic peritoneal dialysis: a pediatric experience. Petit Dial Int 1995; 15: 77–9.

    CAS  Google Scholar 

  267. Churchill DN, Taylor D W, Vas SI et al. Peritonitis in continuous ambulatory peritoneal dialysis (CAPD) patients: a randomized clinical trial of cotrimoxazole prophylaxis. Petit Dial Int 1988; 8: 125–8.

    Google Scholar 

  268. Sharma BK, Smith EC, Rodriguez H, Pillay VKG, Gandhi VC, Dunea G. Trial of oral neomycin during peritoneal dialysis. Am J Med Sci 1971; 262: 175–8.

    Article  PubMed  CAS  Google Scholar 

  269. Low DE, Vas SI, Oreopoulos DG et al. Prophylactic cephalexin ineffective in chronic ambulatory peritoneal dialysis. Lancet 1980; 2: 753–4.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. L. Fried
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Piraino
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Renal Medicine, Manchester Royal Infirmary, Oxford Road, M13 9WL, Manchester, UK

    R. Gokal

  2. Division of Nephrology, Department of Medicine, MA 436 Health Services Centre, University of Missouri-Columbia, 65212, Columbia, MO, USA

    R. Khanna

  3. Academisch Medisch Centrum, Amsterdam, The Netherlands

    R. Th. Krediet

  4. Department of Internal Medicine, MA 436 Health Sciences Center, University of Missouri-Columbia, 65212, Columbia, MO, USA

    K. D. Nolph

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Fried, L., Piraino, B. (2000). Peritonitis. In: Gokal, R., Khanna, R., Krediet, R.T., Nolph, K.D. (eds) Textbook of Peritoneal Dialysis. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-3225-3_17

Download citation

  • DOI: https://doi.org/10.1007/978-94-017-3225-3_17

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-017-3227-7

  • Online ISBN: 978-94-017-3225-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation